Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
9 studies found for:    16702586 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated
Has Results
Boceprevir Drug Combination for Hepatitis C Treatment in People With and Without HIV
Conditions: Hepatitis;   HIV/AIDS
Interventions: Drug: Boceprevir;   Drug: Peg-Interferon-alfa 2B;   Drug: Ribavirin
2 Completed
Has Results
High-Dose Ribavirin and Peginterferon to Treat Chronic Hepatitis C Genotype 1
Condition: Chronic Hepatitis C
Interventions: Drug: Peginterferon;   Drug: Ribavirin
3 Completed
Has Results
S-Adenosyl Methionine (SAMe) to Treat Patients With Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: Peginterferon alfa-2a;   Drug: Ribavirin;   Drug: S-adenosyl methionine for Chronic Liver Disease
4 Completed
Has Results
Study of A Combination Pill With GS-7977 and GS-5885 for Hepatitis C in People With HIV
Conditions: Hepatitis C;   HIV
Intervention: Drug: GS-7977/GS- 5885 FDC
5 Completed
Has Results
GS-7977 With Ribavirin for Hepatitis C (SPARE)
Condition: Hepatitis C
Interventions: Drug: GS7977;   Drug: RBV
6 Completed Combination Therapy for Chronic Hepatitis C Infection
Condition: Hepatitis C, Chronic
Interventions: Drug: Fixed Dose GS-7977/GS-5885;   Drug: FDC with GS-9451;   Drug: FDC with GS-9669
7 Not yet recruiting Hepatitis C Virus(HCV) Heart and Lung Study
Conditions: Hepatitis C, Chronic;   Heart Failure;   Pulmonary Disease, Chronic Obstructive;   Lung Diseases, Interstitial
Intervention: Drug: Sofosbuvir/ledipasvir fixed dose combination(SOF/LDV FDC)
8 Unknown  Prospective Cohort Study: To Provide Evidence & Guidance in Hepatitis C Virus Screening, Comparing the New Birth Cohort Recommendations From the CDC, Versus Classical Traditional Strategies With Established Risk Factors
Condition: Chronic Hepatitis C Virus Infection
Intervention:
9 Terminated Breath Test to Assess Hepatic Metabolic Reserve and to Predict Hepatic Decompensation in Cirrhotics
Condition: Cirrhosis
Intervention:

Study has passed its completion date and status has not been verified in more than two years.